Fredag 18 Juli | 07:32:40 Europe / Stockholm

Kalender

Est. tid*
2025-10-31 07:00 Kvartalsrapport 2025-Q3
2025-07-11 - Kvartalsrapport 2025-Q2
2025-04-30 - Kvartalsrapport 2025-Q1
2025-04-28 - X-dag ordinarie utdelning AKBM 0.00 NOK
2025-04-25 - Årsstämma
2025-02-12 - Bokslutskommuniké 2024
2024-11-01 - Kvartalsrapport 2024-Q3
2024-09-09 - X-dag ordinarie utdelning AKBM 45.00 NOK
2024-09-03 - Extra Bolagsstämma 2024
2024-07-12 - Kvartalsrapport 2024-Q2
2024-04-26 - Kvartalsrapport 2024-Q1
2024-04-17 - X-dag ordinarie utdelning AKBM 0.00 NOK
2024-04-16 - Årsstämma
2024-02-14 - Bokslutskommuniké 2023
2023-11-01 - Kvartalsrapport 2023-Q3
2023-07-14 - Kvartalsrapport 2023-Q2
2023-04-28 - Kvartalsrapport 2023-Q1
2023-04-21 - X-dag ordinarie utdelning AKBM 0.00 NOK
2023-04-20 - Årsstämma
2023-02-15 - Bokslutskommuniké 2022
2022-11-01 - Kvartalsrapport 2022-Q3
2022-07-14 - Kvartalsrapport 2022-Q2
2022-04-29 - Kvartalsrapport 2022-Q1
2022-04-21 - X-dag ordinarie utdelning AKBM 0.00 NOK
2022-04-20 - Årsstämma
2022-02-17 - Bokslutskommuniké 2021
2021-10-29 - Kvartalsrapport 2021-Q3
2021-07-14 - Kvartalsrapport 2021-Q2
2021-04-29 - Kvartalsrapport 2021-Q1
2021-03-15 - X-dag ordinarie utdelning AKBM 0.00 NOK
2021-03-12 - Årsstämma
2021-02-16 - Bokslutskommuniké 2020
2020-10-30 - Kvartalsrapport 2020-Q3
2020-07-15 - Kvartalsrapport 2020-Q2

Beskrivning

LandNorge
ListaOslo Bors
SektorHandel & varor
IndustriDagligvaror
Aker BioMarine är verksamt inom bioteknik. Bolaget är specialiserat inom utveckling av kostillskott. Produktportföljen är bred och inkluderar exempelvis omega-3 olja, näringstillskott för djur, samt proteintillskott för fiskeodling. Verksamheten drivs globalt med störst närvaro inom den nordiska marknaden. Kunderna består av både privata aktörer samt grossister. Aker BioMarine grundades år 2006 och har sitt huvudkontor i Oslo.
2021-02-05 08:39:54
Fornebu, 5 February 2021

Aker BioMarine today takes delivery of its new support vessel Antarctic
Provider, built by China's CIMC Raffles Offshore Ltd. The vessel will set its
course to Antarctica and commence service during first half of 2021.

Despite the challenging global environment and lockdown periods in 2020, the
Antarctic Provider was finalized ahead of expectations. The vessel will replace
Aker BioMarine's existing support vessel, La Manche. Antarctic Provider will
transport krill products, crew, fuel and consumables between the harvesting
vessels and Aker BioMarine's logistics hub in Montevideo, Uruguay.

Antarctic Provider offers several improvements and efficiencies to Aker
BioMarine's offshore operation. The offloading capacity more than doubles,
reducing the number of sailings between the fishing ground and Montevideo.
Faster cargo transshipment at sea increases number of available fishing days for
the fishing vessels. The new support vessel will also improve flexibility and
remove the current need for leasing extra support vessel capacity, altogether
reducing support vessel unit costs approx. 30%. Moreover, service vessel fuel
consumption per unit krill meal produced is estimated to be more than halved,
reducing Aker BioMarine's overall carbon footprint.

The 168-meter vessel is equipped with Wärtsilä 31, four-stroke diesel engine,
combined with a hybrid propulsion system. The engine holds a Guinness World
Record for fuel efficiency and is also convertible for future greener fuels. The
vessel is enhanced with Dynamic Positioning (DP) capabilities, which prevents
the need for anchoring during transshipment.
o The vessel is in full compliance with International Maritime Organization's
(IMO) Polar Code, meeting requirements on hull strength and cold-proofing to
combat the Antarctic climate
o It is outfitted with frequency-controlled thrusters, to avoid zero pitch loss
and reduce underwater noise
o The vessel features four, high-capacity cargo holds (holding up to 40,000
cubic meters) plus moveable cranes on top of each cargo hold
o The vessel will carry Norwegian flag (NIS) and will be classified by DNVGL

With Antarctic Provider as the sole support vessel, the annual cash cost
reduction is estimated to be about USD3-4m. The total capital expenditure for
Antarctic Provider amounted to USD75m, in line with the budget. The vessel is
80% debt financed, including an ECA tranche from GIEK and Export Credit Norway.

For further information, please contact Martin Stenshall, Investor Relations
Mobile: +47 47 33 83 31
Email: martin.stenshall@akerbiomarine.com

About Aker BioMarine
Aker BioMarine is a biotech innovator and Antarctic krill-harvesting company,
dedicated to improving human and planetary health. Listed on Euronext Growth,
the company develops krill-based ingredients for nutraceutical Superba®),
aquaculture (QRILL® Aqua), and animal feed applications (QRILL® Pet), including
INVITM, a highly concentrated protein isolate, and LYSOVETATM, a targeted
transporter of EPA and DHA from krill. Aker BioMarine's fully transparent value
chain stretches from sustainable krill harvesting in pristine Antarctic waters
through its Montevideo logistics hub, Houston production plant, and to customers
around the world. The company's strong focus on sustainability inspired the
launch of AION by Aker BioMarine, a circularity company dedicated to helping
companies to recycle and reuse waste. Read more: www.akerbiomarine.com